RecruitingNot ApplicableNCT06800469

Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer (MIcRobiome Analysis in Patients UnderGoing PancrEatico-duodenectomy for Pancreatic Cancer MIRAGE Study)

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

30 participants

Start Date

Jul 11, 2022

Study Type

INTERVENTIONAL

Conditions

Pancreatic Cancer, Adult

Summary

Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is analyzing how the gut microbiome (the community of bacteria living in your digestive tract) changes in patients undergoing surgery to remove pancreatic cancer. Researchers hope this will reveal how gut bacteria affect recovery and treatment outcomes. **You may be eligible if...** - You are 18 or older - You have been diagnosed with resectable pancreatic cancer (cancer that can be surgically removed) - You are scheduled for upfront surgery (not chemotherapy first) - You are in stable enough health for surgery (ASA score below 4) **You may NOT be eligible if...** - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMicrobiota analysis

Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis

Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, BO, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06800469

Related Trials

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

NCT076296091 location

To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC

NCT075915711 location